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ABSTRACT
Understanding the molecular and bio-
chemical basis of cellular growth and divi-
sion involves the investigation of regulatory
events that most often occur in a cell-cycle
phase-dependent fashion. Studies examin-
ing cell-cycle regulatory mechanisms and
progression invariably require cell-cycle
synchronization of cell populations. Thus,
many methods have been established to syn-
chronize cells at specific phases of the cell
cycle. Several of the common methods in-
volve pharmacological agents, which act at
various points throughout the cell cycle. Be-
cause of adverse cellular perturbations re-
sulting from many of the synchronizing
drugs used, other synchrony methods that
involve less perturbation of biological sys-
tems, such as serum deprivation, contact in-
hibition, and centrifugal elutriation have a
significant advantage. The advantages and
disadvantages of these cell synchronization
methods are discussed in this review.
INTRODUCTION
Gene expression, translation, and
post-translational modifications occur-
ring in a cell-cycle-dependent manner
are crucial for the regulation of cell-cy-
cle progression. Using synchronous
populations of cells from distinct cell
cycle phases allows for the study of
molecular and biochemical events and
their consequences during cell division.
Examples include the inactivation of
the retinoblastoma tumor suppressor
protein (pRB) by hyperphosphorylation
at the restriction point in late G1 (4,36),
expression of cyclin A at the late G1 to
S phase transition (64,65), and the on-
set of cyclin B/Cdc2 activity at the G2
to M phase transition (12,13,66).
Pharmacological agents that arrest
cells at specific phases are commonly
used for synchronization purposes. For
instance, the prevention of DNA initia-
tion at origins of replication by mimo-
sine results in an early G1 arrest (37,44).
Release of early G1 arrest by the re-
moval of mimosine has been cited to el-
evate p53 and p21 protein levels; there-
fore, these findings should be taken into
account when using this drug for syn-
chronization (26). Arrest in early G1 is
also achieved by treatment with lovas-
tatin, a mevalonate synthesis inhibitor
(20,25,30,35); however, lovastatin has
recently been demonstrated to effective-
ly induce apoptosis in a variety of cell
lines (27,49,53,55). Hydroxyurea or
thymidine treatment arrests cells in S
phase by targeting ribonucleotide reduc-
tase (56). When studying later cell-cycle
phases, drugs used to synchronize cells
from the G2/M phases can be advanta-
geous. Microtubule-disrupting agents,
such as nocadozole and colcimid, arrest
cells in M phase (41). Following their
removal, these drugs provide synchro-
nous cell populations, but metabolic
perturbations and toxicity are likely to
occur. The manipulation of cells using
synchronizing agents has been demon-
strated to causally promote side effects,
such as dissociation of nuclear and cyto-
plasmic cell-cycle processes, disruption
in the metabolic state of the cell, and cell
death (32–34,51).
In contrast, several drug-indepen-
dent methods have been established for
synchronizing cells from asynchronous
cell populations. Among these methods
include G0 quiescence by serum depri-
vation (50,57), isolation of early G1
cells by cell contact inhibition (7,9),
and centrifugal elutriation of cells in
any phase of the cell cycle. Mitotic
shake-off is also a nondisruptive meth-
od of isolating mitotic cells (2,19,24).
Monolayer cells entering mitosis group
together and become loosely attached
to the dish so that they can be isolated
by shaking the dish. Medium is subse-
quently transferred to another dish, and
cells are allowed to attach upon G1 en-
try. However, the limitation of this
method is that the yield of cells is very
low and, thus, cannot be used for sever-
al types of experiments. Because of po-
tential adverse cellular consequences of
synchronizing cells by pharmacological
agents, we have chosen to focus on
three cell synchrony methods involving
minor cell manipulation: serum depri-
vation, contact inhibition, and centrifu-
gal elutriation. However, when choos-
ing a particular cell synchronization
method, cell type, the cell-cycle phase/
event to be studied, the doubling time of
the cell cycle, and the duration of each
cell-cycle phase should be considered.
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SERUM DEPRIVATION
The transition between G0 quies-
cence and early G1 is regulated by
growth-stimulatory and growth-in-
hibitory factors present in the extracel-
lular environment. Control of the G0
quiescence-early G1 transition is, in
part, mediated through mammalian D-
type cyclins that are upregulated in the
presence of growth factors and facilitate
early G1 progression (42,62,61). Cell-
cycle exit into G0 quiescence can thus
be achieved by removing serum, which
contains mitogenic factors from the cell
culture medium (1,39). Cell-cycle syn-
chrony is achieved following the addi-
tion of serum back to the medium to
stimulate cell-cycle entry into the early
G1 phase. However, the effectiveness of
this method relies on the susceptibility
of cells to exit into G0 quiescence fol-
lowing the serum withdrawal. G0 quies-
cence is often difficult to achieve in
transformed cells, but primary and im-
mortalized cells may exhibit decreased
viability in low-serum conditions. It
must be noted that serum deprivation
induces cell exit into the G0 compart-
ment, which results in the transcription-
al repression of several cell-cycle regu-
latory genes, such as cyclins and
cyclin-dependent kinases (Cdks) (43).
Therefore, entry into the G1 phase of
the cell cycle from G0 quiescence does
not necessarily reflect the G1 progres-
sion following the completion of the M
phase, which would be applicable for
studying the early G1 phase of cycling
cells, such as tumor cells. Factoring in
the eventual loss of cell synchrony as
cells progress through the later phases
of the cell cycle is also of importance.
To achieve a G0 arrest, cells are
seeded at subconfluent conditions in
high serum-containing medium
(5%–10% serum). Following 18–24 h,
cells are washed multiple times with
PBS, and medium containing low
serum amounts is added back to the
cultures (60,68). The exit into G0 quies-
cence by the majority of cells requires
different periods of time in reduced-
serum conditions, depending on cell
type. For example, G0 quiescence is
achieved by NIH3T3 cells when they
are maintained in the presence of 0.2%
serum for 24 h (60). Studies have
demonstrated that G0 quiescence oc-
curs in at least 95% of diploid fibrob-
lasts (68) within 48 h of being in 0.1%
serum; however, longer periods (48–72
h) under serum deprivation conditions
are often required for many cell types.
To determine the percentage of cells
exiting quiescence and progressing
through the cell cycle, cells entering S
phase can be monitored by BrdU incor-
poration (5,17) or staining with propid-
ium iodide for DNA content, followed
by analysis using a flow cytometer
(58,59,67). Distinguishing quiescent
cells from G1 cells can be achieved by
examining Cdk4:cyclin D activity (15)
and the proliferation marker Ki67 (30).
It is important to note that, when G0
quiescent cells enter early G1 upon
serum stimulation, synchrony occurs
only to a certain degree depending on
the cell type. Not all cells enter into
early G1 from G0 quiescence, and those
cells that do enter early G1 do not nec-
essarily progress through the cell cycle
at the same rate (Figure 1A) (14,45). In
fact, variability of cell-cycle kinetics is
inherent from cell to cell and occurs to
some extent using any synchronization
method. After the addition of serum
back to the medium, a significantly
greater number of normal cells in com-
parison to tumor cells may remain be-
hind in G0 quiescence. As the cells con-
tinue to progress through the cell cycle
into late G1 phase and S phase follow-
ing serum addition, the differential
rates of cell-cycle progression within
the cell population continue to increase
and thereby generate unsynchronized
cells (Figure 1A). This is an important
factor that should be taken into consid-
eration when analyzing and interpret-
ing data from experiments using this
method of synchrony.
CONTACT INHIBITION
The phenomenon of contact inhibi-
tion in cell culture conditions occurs as
cells continually divide, resulting in
high cell density and cell-to-cell con-
tact. At this point, cells undergo an ar-
rest in the early G1 phase of the cell cy-
cle; this is unlike serum deprivation,
which results in G0 quiescence (47,69).
Cell type determines the degree to
which the cells arrest in early G1 as a
result of high cell density conditions.
Normal cells and some transformed
cells exhibit contact inhibition, but a
subpopulation of cells may exist that
are resistant to early G1 arrest under
these conditions. Contact inhibition, in
conjunction with serum withdrawal,
may yield an increased number of cells
arrested in early G1, which may aid in
the arrest of tumor cells in particular.
Although contact inhibition-mediated
early G1 arrest may involve p27, a Cdk2
inhibitor, as indicated by several studies
reporting the accumulation of p27 in
contact inhibited cells (3,54), fibrob-
lasts from p27 knockout mice strongly
suggest the involvement of additional
unknown mechanisms during the con-
tact inhibition process (46). Similar to
synchronization by serum deprivation,
processes mediated by contact inhibi-
tion may affect the protein of interest
and should be considered when choos-
ing this method of synchrony.
Contact inhibition can be achieved
in human diploid fibroblasts by allow-
ing cells to reach 89% confluency. The
fibroblasts are then replated at high-
density conditions (6 × 106 cells/10-cm
plate) that have been experimentally
predetermined to elicit an early G1 ar-
rest. Reduction of serum (from 5% to
0.5%) in the medium may aid contact
inhibition of certain cell types. The de-
gree of early G1 arrested cells within a
population can be distinguished from
those progressing through S, G2, and M
phases by the analysis of DNA content
using flow cytometry (58,59,67). In our
laboratory, greater than 90% of cul-
tured human diploid fibroblasts arrest
in early G1 when they are maintained at
confluency for 48 h (A.H. and S.F.D.,
personal observations). To release cells
from contact inhibition, cells are replat-
ed at low density (1 × 106 cells/10-cm
plate), and the progression of the cells
into subsequent phases is monitored by
DNA content analysis using flow cy-
tometry and BrdU incorporation. Fur-
ther analysis can be carried out to deter-
mine which cells are progressing
through the restriction point in late G1
and entering S phase. At the restriction
point, hyperphosphorylation of pRB
occurs, which can be detected by slow-
er migration using SDS-PAGE (15,18,
40). Greater than 50% of cells traverse
into S phase 25 h after replating (A.H.
and S.F.D., personal observations).
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Replating contact-inhibited cells at
low density results in continued cell-cy-
cle progression from early G1. While
the majority of cells will be synchro-
nous at this time, some cells may
progress at different rates and have a
delayed response to cell-cycle progres-
sion from early G1 (Figure 1B). The de-
gree of cell-cycle synchrony will lessen
with time after low density replating of
the contact inhibited cells. In addition,
the differential rates of progression by
cell populations become more signifi-
cant as cells enter later phases of the
cell cycle (Figure 1B). An important
consideration when designing and ana-
lyzing experiments is the fact that, in
most instances, only the majority of the
cell population will be synchronous at a
given time following release from con-
tact inhibition. Synchronization of fi-
broblasts by contact inhibition can al-
low examination of early G1-specific
events (Figure 2). In our laboratory, we
used synchronized fibroblasts following
contact inhibition measurements of cy-
clin D:cdk4/6 activity, pRB phosphory-
lation, and cyclin E:cdk2 activity. As fi-
broblasts progress from early to late G1,
cyclin D:Cdk4/6 activity is maintained
throughout G1, while cyclin E:Cdk2 ac-
tivation occurs concurrent with pRB
hyperphosphorylation as cells traverse
into late G1 phase (Figure 2).
CENTRIFUGAL ELUTRIATION
In theory and in practice, cells in a
particular phase of the cell cycle can be
isolated based on size, using the
method of centrifugal elutriation. For
instance, early G1 cells are approxi-
mately half the size of cells in the late
G2 or M phase, while S phase cells ex-
hibit an intermediate size. To ensure
successful isolation of phase-specific
populations by elutriation, it should be
noted that some cell types may not ex-
hibit significant size variability as they
progress through the cell cycle. Al-
though the centrifugal elutriation setup
requires specially designated equip-
ment, this method offers several signifi-
cant biological advantages compared
with other methods of cell-cycle syn-
chronization. First, centrifugal elutria-
tion can be used to isolate almost all
cell types, adherent or suspension, in-
cluding Rat1 fibroblasts (22), Swiss
3T3 cells (23,72), NOSE-1 epithelial
cells (70), NB41A3 neuroblastoma
cells (73), primary dipoloid fibroblasts
(22,23), Jurkat leukemia cells (38), and
HT-29 adenocarcinoma cells (31). Sec-
ond, this method does not require ex-
posing the cells to pharmacological
agents or maintaining them in stress-in-
ducing environments, such as low-
serum and high-density conditions.
Third, elutriation can be used to acquire
cell populations from any phase of the
cell cycle and yield a large population
of phase-specific cells rapidly isolated
for subsequent analysis. Finally, once
the elutriation parameters are estab-
lished for a given cell type and cell-cy-
cle position, centrifugal elutriation can
be consistently repeated.
The method of centrifugal elutria-
tion consists of a specially designed
centrifuge rotor in which the centrifu-
gal force on the cell population is coun-
tered by medium flowing in the oppo-
site direction (Figure 3). Cells are
injected by the use of a pump into the
elutriation rotor, which is spinning at a
constant g force. When the centrifugal
force of the rotor (proximal to distal;
see Figure 3) is balanced with the op-
posing force of the flow rate (distal to
proximal), cells float at a specific posi-
tion within the elutriation chamber,
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Figure 1. Comparative depiction of relative starting points for cells synchronized by serum depri-
vation versus contact inhibition. (A) Serum deprivation results in cell-cycle exit into G0 quiescence,
whereas (B) contact inhibition leads to an early G1 arrest-like position. Like most cell synchrony meth-
ods, cells following the release of cell-cycle arrest or G1 entry from quiescence will not progress through
the subsequent phases at the same rate. Note: upon restimulation or replating, not all cells traverse equal-
ly efficiently through the subsequent phases of the cell cycle; some cells become more unsynchronized in
the later phases of the cell cycle.
based on their size. Hence, small, early
G1 phase cells are proximal, while the
larger G2/M phase cells are distal. As
the flow rate is increased, the proximal
early G1 cells are elutriated or pushed
out of the chamber and collected. By
further increasing the flow rate, the late
G1 phase cells can then be elutriated
and collected, followed by the S phase
and then G2/M phase cells. Important-
ly, throughout the entire process, cells
are maintained at 34°C–37°C in the
presence of serum-containing medium
and, thus, are exposed to minimal bio-
logical perturbations. Parameters such
as rotor speed, number of cell injected,
flow rate, and volume of the cell frac-
tions collected must be taken into ac-
count when establishing elutriation
conditions for a particular cell type.
Determining the cell-cycle phase (i.e.,
G1, S, and G2/M phases) of a popula-
tion can be carried out by analyzing the
DNA content by flow cytometry (Fig-
Review
Figure 2. Analysis of contact-inhibited cells. Human (HaCaT) keratinocytes were contact inhibited for
48 h at high density in 10% serum, released by replating at low density, and then assayed at the indicated
times. Immunoblot analysis was performed as described (15) with anti-pRB (BD Biosciences, San
Diego, CA, USA). Anti-Cdk2 and anti-Cdk6 (both from Santa Cruz Biotechnology, Santa Cruz, CA,
USA) immunoprecipitation kinase assays were performed using GST-pRB C′ terminus or histone H1 as
the substrate in vitro, according to Ezhevsky et al. (15).
ure 4). The analysis of cell viability
within each elutriated fraction can also
be carried out using light-scatter tech-
niques with flow cytometry.
The entire elutriation typically takes
1–2 h and can yield as many as 107
pure early G1 cells. We have success-
fully elutriated multiple cell types, both
adherent and suspension. Elutriation of
several cell types yields highly en-
riched, phase-specific cell populations
(10,21,23,29). As with the previous
methods discussed, the phase-specific
cell population may be contaminated to
some extent with cells from other phas-
es. Following the isolation of phase-
specific cell population, the cells can
either be replated and followed through
various phases of the cell cycle or be di-
rectly examined for phase-specific ex-
pression profiles (Figure 4).
DISCUSSION
Here, we describe that the most im-
portant parameters to be considered
when choosing a method of cell syn-
chrony are the cell-cycle events/phases
to be studied and the properties of the
cells used. Methods that induce cell-cy-
cle arrest in a particular phase of the
cell cycle may involve different cellular
mechanisms that can potentially affect
the cellular event, protein studied,
and/or the biology of the cell. This was
illustrated in a study that reported dif-
ferences in regulatory molecules during
G0 quiescence of human diploid fibro-
blasts induced by serum deprivation
versus contact inhibition in the pres-
ence of serum (9). While the accumula-
tion of p27 and p16 Cdk inhibitors oc-
curs in contact-inhibited early G1 phase
fibroblasts, these proteins remain low in
G0 quiescence serum-deprived cells (9).
In contrast, centrifugal elutriation
offers a significant advantage over
serum deprivation and contact inhibi-
tion because elutriation provides cell-
cycle phase-specific cells from cycling
cells, including normal and tumor cells.
The importance of selecting synchrony
methods involving alterations of cells
compared to unaltered elutriated cells is
demonstrated by studies examining D-
type cyclins. Studies using G0 quiescent
serum-deprived cells exhibited a mid-
G1 expression pattern of D-type cyclins
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Figure 4. Analysis of centrifugally elutriated cells. Human Jurkat T cells were separated, based on size
by elutriation and the various fractions of cell-cycle phase-specific populations collected. Cell-cycle po-
sition was analyzed by DNA content with propidium iodide using flow cytometry (top) (54,55,61). To
further demonstrate the temporal cell-cycle position of the cells, Rb protein was examined by im-
munoblot analysis using anti-Rb (BD Biosciences) (36). In early G1, Rb becomes hypophosphorylated,
but as cells progress through the restriction point approaching late G1, Rb becomes hyperphosphorylated
(noted by an upward shift in mobility using SDS-PAGE).
Figure 3. Standard centrifugal elutriation chamber. Cells become balanced in the chamber by the
countering centrifugal and flow forces. Small (G1 phase) cells are forced into the proximal end of the
chamber, whereas the larger (G2/M phase) cells remain at the distal end of the chamber. Once cells cross
the elutriating boundary, the flow rate dramatically increases because of the narrowing of the chamber,
and the cells become captured and exit the chamber.
(63). Indeed, this result supported a hy-
pothesis that D-type cyclins, in con-
junction with their Cdk partners, Cdk4
and Cdk6, performed the initial inacti-
vating hyperphosphorylation of pRB at
the late G1 restriction point. However,
analysis of cyclin D expression and ac-
tivities from elutriated cycling cells and
contact-inhibited cells demonstrated a
constitutive cell-cycle pattern of cyclin
D:Cdk4 expression and kinase activity
(11) throughout the cell cycle (Figures
2 and 4). These observations directly
challenge the notion previously held
from serum-deprived experiments.
Therefore, the use of unaltered syn-
chronized cells resulting from elutria-
tion may have a significant impact on
previous findings from studies that re-
lied on methods involving cell stress.
Phase-specific cells can also be ob-
tained by the use of flow cytometry and
cell sorting using DNA content analysis
(an indicator of cell cycle phase) and
cell size (an indicator of cell viability)
as the sorting criteria (48,52). Depend-
ing on the study, cells can be fixed for
phase-specific markers, such as cyclin
B (71) and AF-2 protein (8), before cell
sorting by flow cytometry to acquire
very pure and specific subpopulations
of phase-specific cells (28).
Finally, synchronous populations of
cells can be achieved by stimulating
naturally G0 quiescent cells to enter the
cell cycle. Primary peripheral blood
lymphocytes exist in a G0 quiescent
state until stimulated to undergo cell di-
vision, which can be done by treatment
with polyclonal mitogens, such as phy-
tohemagglutinin and concanavalin A
for T cells and lipopolysaccharide for
mouse B cells. For example, treatment
of  G0 quiescent primary peripheral
blood lymphocytes with phytohemag-
glutinin drives these cells into early G1
phase of the cell cycle, with subsequent
progression into S phase at approxi-
mately 36 h after stimulation (6,16).
While several methods of synchrony
cells exist, the consequences of these
methods on the overall physiology of
the cell and the impact that the chosen
method may have on the particular ex-
periments to be carried out should be
kept in mind. If possible, preliminary
experiments using different methods of
synchrony should be conducted to ad-
dress these issues.
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